Measles Vaccine Allergy: Why Gelatin (Not Egg) Is the Real Allergen
Measles vaccine allergy is almost always caused by hydrolyzed gelatin, not egg protein, despite decades of outdated egg-allergy warnings. In US VAERS data, 27% of anaphylaxis cases after MMR had anti-gelatin IgE antibodies. M-M-R II contains 14.5 mg gelatin and only 0–1 ng residual ovalbumin. Anaphylaxis is rare at roughly 1 per million doses, and egg allergy is no longer a contraindication. Gelatin-allergic patients need allergist evaluation before vaccination.
Free · 5 min · Insurance accepted
Key facts
In US VAERS data, 27% of anaphylaxis cases after MMR had anti-gelatin IgE antibodies — confirming gelatin, not egg protein, as the primary MMR allergen.
M-M-R II contains 14.5 mg hydrolyzed porcine gelatin per dose versus only 0–1 ng residual ovalbumin — approximately 14 million times less egg protein than the reaction threshold.
MMR anaphylaxis occurs at approximately 0.6 per million doses distributed (VAERS) and 5.1 per million administered (Vaccine Safety Datalink) — an extremely rare but real event.
Multiple studies of over 1,200 egg-allergic individuals confirm MMR is safe in egg allergy; egg allergy is no longer a precaution or contraindication per ACIP, AAAAI, or the Red Book.
Gelatin allergy warrants allergist evaluation before MMR, MMRV (ProQuad), varicella (Varivax), and some Japanese encephalitis and rabies vaccines, all of which use gelatin as a stabilizer.
What Is Measles Vaccine Allergy?
Measles vaccine allergy is an IgE-mediated immediate hypersensitivity reaction to excipients in the measles-containing vaccine, most often hydrolyzed gelatin rather than the measles virus itself or any egg protein.
The only measles vaccines licensed in the United States are combination products — M-M-R II (Merck) and Priorix (GSK, licensed 2022) — both of which pair live-attenuated measles virus with mumps and rubella antigens. There is no measles-only vaccine available in the US.
The word 'allergy' in this context is clinically narrow. True IgE-mediated anaphylaxis after MMR is extraordinarily rare, occurring in roughly 0.6 cases per million doses distributed (VAERS) and 5.1 per million administered according to CDC Vaccine Safety Datalink data. The rash, fever, and transient joint discomfort that sometimes follow MMR are NOT allergic reactions — they reflect expected immune responses to live-attenuated viral replication.
For decades, patients with egg allergy were warned to avoid MMR. This guidance is outdated. Multiple studies of more than 1,200 egg-allergic individuals confirm MMR is safe in egg allergy, and egg allergy is no longer listed as a precaution or contraindication by ACIP, AAAAI, or the Red Book. The real allergen concern — in the small number of patients who truly react — is gelatin.
Symptoms of Measles Vaccine Allergic Reactions
Recognizing symptoms early helps you get the right treatment faster.
Urticaria (hives)
moderateRaised, itchy wheals appearing within minutes of vaccination, often starting at the injection site and spreading. A classic IgE-mediated sign.
Angioedema
severeDeep swelling of the lips, face, tongue, or throat. Throat or tongue angioedema threatens the airway and requires immediate epinephrine and emergency care.
Bronchospasm and wheezing
severeTightening of the lower airways producing audible wheeze, cough, and shortness of breath — more likely in patients with baseline asthma.
Anaphylaxis
severeMulti-system involvement with hives plus airway, breathing, or cardiovascular compromise, occurring typically within 15 minutes of the injection. A medical emergency.
Injection-site soreness and redness
mildCommon, expected, and non-allergic. Mild local reactions resolve within 1 to 3 days without treatment.
Post-vaccination fever
mildLow-grade fever appearing 5 to 12 days after MMR is an expected immune response to live viral replication — NOT an allergic reaction and not a contraindication to future doses.
Morbilliform rash
mildA faint measles-like rash appearing 7 to 10 days after MMR in roughly 5% of recipients, caused by attenuated viral replication. Self-limited and not allergic in mechanism.
Transient thrombocytopenia
A rare drop in platelet count (approximately 1 in 30,000 doses) occurring 2 to 3 weeks post-vaccination. Self-limited in most cases but warrants pediatric follow-up.
When to see a doctor
Allergic reactions to MMR present on a spectrum from localized skin reactions to systemic anaphylaxis. The clinically important distinction for parents and patients is between an allergic reaction (minutes after the injection) and an expected vaccine response (days later, usually fever and rash). The latter is not an allergy and does not contraindicate future doses. True anaphylaxis can involve any combination of hives, throat or tongue swelling, wheezing, stridor, vomiting, hypotension, and loss of consciousness. If any of these appear within an hour of vaccination, seek emergency care immediately and carry epinephrine if prescribed. Injection-site reactions — redness, swelling, soreness — are common and are not allergic. A rarer Arthus-type reaction (Type III immune complex) can produce severe local swelling 4 to 12 hours after injection in heavily hyper-immune individuals, typically with repeated toxoid boosters rather than MMR. Report any serious event to VAERS and to your allergist for formal evaluation.
MMR, Gelatin Allergy, and Asthma
Children and adults with well-controlled asthma can safely receive MMR — asthma itself is not a precaution, contraindication, or risk factor for vaccine allergy. The indirect link is through atopy: patients with atopic dermatitis, food allergies, and asthma share a higher baseline probability of harboring IgE antibodies to dietary proteins including gelatin. If a child with severe atopic disease has a history of reacting to gummy candies or gelatin capsules, that history matters more than the asthma diagnosis itself. Patients with poorly controlled asthma at the time of vaccination should have baseline peak flow and oxygen saturation checked before any subcutaneous injection, because the risk of any adverse event is higher when airway reserve is compromised. This is a general principle, not specific to MMR.
Complications of Misidentified MMR Allergy
The most common 'complication' of MMR allergy labeling is not a medical event but a public health one: unnecessary vaccine avoidance. A mislabeled egg allergy or an exaggerated report of a mild local reaction can lead to skipped doses, unprotected children, and outbreak risk. The US has experienced multiple measles outbreaks since losing its elimination status in 2019, driven largely by under-vaccination, not by true allergy. Genuine complications of a real allergic reaction are anaphylaxis-related — airway compromise, shock, and in rare cases cardiac arrest. Anaphylaxis is nearly always reversible with prompt epinephrine and supportive care. Long-term sequelae are uncommon. A separate clinical dilemma involves patients with confirmed gelatin anaphylaxis who still need measles protection. Desensitization protocols in an allergist's office, using graded fractional dosing with emergency preparedness, allow most such patients to receive the vaccine safely under observation. Published case series support this approach.
Unnecessary vaccine avoidance
Mislabeling a mild local reaction or outdated egg-allergy warning as MMR allergy can lead to missed doses and outbreak vulnerability. Formal allergist review can safely de-label most patients.
Anaphylaxis
Rapid-onset multi-system allergic reaction requiring epinephrine. Occurs in roughly 1 per million MMR doses and is nearly always reversible with prompt treatment.
Transient thrombocytopenic purpura
A rare post-MMR drop in platelets (~1 in 30,000 doses). Not allergic in mechanism but warrants pediatric hematology follow-up.
Febrile seizures
Slightly increased rate of febrile seizures 7 to 12 days post-MMR, especially with the combined MMRV (ProQuad) product at first dose in the 12 to 47-month age window.
Causes of Measles Vaccine Allergic Reactions
The dominant cause of anaphylaxis after MMR is sensitization to porcine hydrolyzed gelatin, a stabilizer added to protect the live-attenuated virus from temperature damage. M-M-R II contains 14.5 mg of hydrolyzed gelatin per dose — by far the largest mass of any potentially allergenic excipient in the product. A landmark 2002 study by Pool and colleagues at the CDC found that 27% of patients with MMR anaphylaxis had measurable anti-gelatin IgE antibodies. Earlier Japanese work by Sakaguchi had established the same pattern in a population with higher baseline gelatin consumption.
How it works
Gelatin anaphylaxis is a classic Type I IgE-mediated reaction. Dietary gelatin exposure sensitizes atopic individuals, generating IgE antibodies against bovine and porcine collagen-derived peptides. When the vaccine delivers a large subcutaneous dose of hydrolyzed gelatin, surface-bound IgE on mast cells and basophils cross-links, triggering rapid degranulation and release of histamine, tryptase, leukotrienes, and platelet-activating factor. Clinical signs appear within minutes: urticaria, angioedema, bronchospasm, hypotension. Alpha-gal syndrome patients may be at additional risk because of shared mammalian carbohydrate epitopes in porcine gelatin.
When Japanese manufacturers reformulated vaccines to remove or reduce gelatin in the late 1990s, immediate-type reaction rates fell substantially — a natural experiment confirming the causal link. Secondary excipients of concern include 25 µg of neomycin (typically a Type IV contact dermatitis issue, NOT a contraindication unless anaphylactic), trace fetal bovine serum, sorbitol, and human serum albumin.
Measles and mumps viral components are grown in chick embryo fibroblast cell culture — NOT whole eggs — which leaves only trace ovalbumin at the 0–1 nanogram level. That amount is immunologically insignificant, which is why the egg-allergy precaution has been formally dropped. The rubella component is grown in WI-38 human diploid cells and contributes zero egg protein.
Risk factors to watch for
Known gelatin food allergy
Children and adults with prior reactions to gelatin-containing foods — gummy candies, marshmallows, jello, gelatin capsules — are at measurably higher risk of MMR anaphylaxis and should be evaluated by an allergist before vaccination.
Alpha-gal syndrome
Patients sensitized to galactose-alpha-1,3-galactose through tick bites (most commonly Lone Star ticks in the southeastern US) may cross-react to mammalian gelatin in vaccines and warrant pre-vaccination assessment.
Prior anaphylaxis to a gelatin-containing vaccine
A documented reaction to MMR, Varivax, RabAvert, YF-VAX, or intranasal FluMist suggests possible gelatin IgE and justifies specialist workup before repeat vaccination.
Neomycin anaphylaxis (not contact dermatitis)
True IgE-mediated anaphylaxis to topical neomycin is a contraindication. Routine neomycin contact dermatitis from topical antibiotics is NOT a contraindication — ACIP explicitly permits vaccination in this common scenario.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Measles Vaccine Allergy
Suspected MMR allergy requires in-person allergist evaluation — not at-home testing. The workup focuses on identifying the responsible excipient, because management differs significantly depending on whether the trigger is gelatin, neomycin, or something else. Start with a detailed history: what were the symptoms, how long after the dose, was epinephrine given, and is there a history of gelatin food reactions. Serum tryptase drawn within a few hours of the event can support the diagnosis of true anaphylaxis. Specific IgE testing for bovine and porcine gelatin is commercially available and is the first-line confirmatory test when gelatin allergy is suspected. Skin prick testing with the vaccine itself, followed by intradermal testing if prick is negative, is performed under allergist supervision when excipient-specific testing is inconclusive. Neomycin allergy is tested by patch testing (Type IV) unless anaphylaxis is suspected, in which case prick or intradermal testing is used. At-home testing like Curex's 40+ environmental allergen panel (5 days, insurance accepted) can characterize background atopy, but suspected gelatin, neomycin, or polysorbate 80 allergy requires allergist evaluation — specific IgE testing or skin testing under observation. Vaccine excipient IgE is not part of any at-home allergy panel.
Gelatin-specific IgE (ImmunoCAP)
A blood test measuring IgE antibodies to bovine and porcine gelatin. This is the most informative first-line test in a patient with suspected vaccine anaphylaxis because gelatin is the dominant excipient allergen in MMR, Varivax, and several other live vaccines.
Skin prick and intradermal testing with MMR vaccine
Graded testing with the full vaccine product, performed in an allergy clinic with resuscitation equipment on hand. A negative protocol allows cautious administration of a full dose; a positive protocol triggers desensitization planning.
Serum tryptase (acute)
Drawn within 1 to 4 hours of an acute reaction, elevated tryptase supports the diagnosis of mast cell activation and true anaphylaxis. Baseline tryptase a few weeks later rules out mastocytosis.
Neomycin patch testing
Type IV contact allergy testing for neomycin sensitivity. A positive patch test to topical neomycin is NOT a contraindication to MMR — only true anaphylaxis to neomycin is.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Unlike hay fever or dust mite asthma, vaccine component allergy cannot be prevented or cured with conventional allergen immunotherapy. SCIT (subcutaneous immunotherapy, or 'allergy shots') and SLIT (sublingual immunotherapy, or 'allergy drops') are designed to induce tolerance to environmental aeroallergens that patients encounter repeatedly over years — pollens, dust mites, pet dander, molds. They are not FDA-approved or clinically indicated for gelatin, neomycin, or any vaccine excipient. For patients with confirmed gelatin IgE who must receive MMR, the relevant procedure is short-course vaccine desensitization in an allergist's office — not chronic immunotherapy. This is distinct from classic ASIT in both mechanism and duration: a single supervised session versus years of maintenance dosing. Curex's sublingual immunotherapy drops ($39/month) treat IgE-mediated environmental allergies — dust mites, pollens, pet dander, molds. Vaccine-component allergy is outside this scope; patients with confirmed gelatin IgE work with an allergist for desensitization protocols when vaccination is essential. The two programs address completely different immune problems and are not interchangeable.
Allergist evaluation and excipient-specific IgE
The starting point is identifying whether the true allergen is gelatin, neomycin, or something else. Testing is personalized based on history.
Risk-benefit assessment
Weigh the outbreak risk, travel plans, and occupational exposure against the documented reaction severity.
Supervised graded dosing in clinic
If vaccination is indicated, the allergist administers the dose in fractional increments with monitoring and rescue medications ready.
Post-vaccination observation
A 2 to 4-hour observation period follows any desensitization protocol, with discharge planning and epinephrine prescribed for home.
“Published case series report successful graded dosing in the majority of supervised attempts for gelatin-allergic patients requiring MMR, though data are limited to small series rather than randomized trials.”
Treat your Measles Vaccine allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With a Confirmed MMR Allergy
A confirmed MMR or gelatin allergy is a specific medical label, not a general 'do not vaccinate' order. Most patients can still receive protection through supervised graded dosing, alternative formulations where available, or — in outbreak exposure — post-exposure immunoglobulin. Keeping a written vaccine allergy action plan, carrying an epinephrine autoinjector if indicated, and wearing a medical alert bracelet are practical steps that protect the patient across clinical settings. Parents of children with confirmed gelatin allergy should coordinate with the school nurse, daycare, and primary care clinician so that any future vaccination decision is reviewed in advance. Communicate the allergy clearly to all providers, including dentists and anesthesiologists, since some medications and medical devices also contain gelatin.
Keep a written vaccine allergy action plan
Document the specific excipient implicated (gelatin, neomycin, or unknown), the reaction history, the allergist's recommendations, and emergency contacts. Bring the plan to every medical visit.
Carry epinephrine if prescribed
Patients with prior anaphylaxis should carry two autoinjectors and know how to use them. Replace expired devices promptly and practice with a trainer.
Medical alert identification
A bracelet or wallet card listing 'gelatin allergy' or 'vaccine anaphylaxis' helps emergency responders avoid triggers if the patient cannot speak.
Coordinate with school and daycare
School nurses need a current vaccine action plan, an epinephrine supply, and clear instructions for field trips and away-from-school events.
Seasonal Patterns
January - December
medium intensity
Prevention Tips
Screen for gelatin food reactions
Ask every patient and parent about reactions to gummy candies, gelatin capsules, marshmallows, or jello. A positive history warrants allergist referral before MMR.
Do NOT screen for egg allergy
Egg allergy is no longer a contraindication or precaution for MMR. Time spent asking about eggs distracts from the more relevant gelatin question.
Observe 15–30 minutes post-dose
Most true anaphylaxis appears within 15 minutes. A short observation window catches immediate reactions at the point where epinephrine is most effective.
Stock epinephrine at every vaccination site
Emergency preparedness — trained personnel, epinephrine, oxygen, and an action plan — is the single most important structural prevention measure.
Prognosis and Outlook
The prognosis for MMR allergy is generally excellent. True anaphylaxis is rare, responds well to epinephrine, and can usually be managed long-term through a combination of accurate excipient identification and supervised vaccination strategies. Most patients eventually receive full measles protection, either through desensitization or through natural exposure with post-exposure immunoglobulin backup. The broader public health outlook depends on accurate allergy labeling. When patients with only mild local reactions or outdated egg-allergy warnings are mislabeled as 'MMR allergic,' the cascade of unnecessary avoidance contributes to outbreak risk. Evidence-based de-labeling by allergists is an important population-level intervention.
Key takeaways
Gelatin — not egg — is the dominant MMR allergen; 27% of MMR anaphylaxis cases have anti-gelatin IgE.
Egg allergy is NOT a contraindication to MMR and has been removed from ACIP, AAAAI, and Red Book precautions.
True MMR anaphylaxis is extraordinarily rare at roughly 1 per million doses and is nearly always reversible with prompt epinephrine.
Most patients with 'MMR allergy' labels can be safely vaccinated after formal allergist evaluation.
Delayed fever or rash 5 to 12 days after MMR is an expected live-virus response, not an allergy.
Diet and Gelatin Sensitization
Dietary gelatin exposure is how most people become sensitized in the first place. In populations with heavier gelatin consumption — gummy candies, gelatin desserts, gelatin-capsule supplements, marshmallows, some yogurts — anti-gelatin IgE is more prevalent. Alpha-gal syndrome, driven by tick bites, creates a parallel risk by sensitizing patients to mammalian carbohydrate epitopes shared with bovine and porcine gelatin. There is no evidence that dietary gelatin restriction prevents future MMR reactions in the general population, and routine avoidance is not recommended. Patients with confirmed gelatin IgE should, however, work with their allergist on individualized dietary guidance alongside vaccine planning.
Foods to limit
Gelatin-containing candies
Gummy bears, gummy worms, gelatin-based fruit snacks, and marshmallows contain concentrated porcine or bovine gelatin that can trigger reactions in sensitized individuals.
Gelatin dessert mixes
Jello and similar mixes are predominantly gelatin and are a common exposure route for anaphylaxis in children with gelatin IgE.
Gelatin capsule supplements
Many over-the-counter vitamin and supplement capsules are made from gelatin — patients with confirmed IgE should request vegetarian (HPMC) alternatives.
The historical egg-allergy precaution for MMR was never based on sound evidence — the amount of ovalbumin in these vaccines is trivial. The real clinical concern is gelatin, and gelatin-allergic patients need allergist evaluation before receiving MMR, MMRV, and varicella vaccines that use hydrolyzed porcine gelatin as a stabilizer.
Frequently Asked Questions
No. The egg-allergy warning for MMR has been formally removed. Measles and mumps viral components are grown in chick embryo fibroblast cell culture, not whole eggs, and the residual ovalbumin content of M-M-R II is 0 to 1 nanogram per dose — far below any clinically significant threshold. Multiple prospective studies of more than 1,200 egg-allergic individuals have documented safe MMR administration without special precautions. ACIP, AAAAI, and the American Academy of Pediatrics Red Book all explicitly state that egg allergy is not a reason to defer or split MMR dosing. Children with severe egg allergy can and should receive MMR on the routine schedule.
Hydrolyzed gelatin serves as a stabilizer protecting the live-attenuated measles, mumps, and rubella viruses from thermal and mechanical degradation during storage and transport. M-M-R II contains 14.5 mg of porcine hydrolyzed gelatin per dose — the largest mass of any excipient in the product. Without a stabilizer, the fragile viral particles would lose potency between manufacturing and administration. Gelatin was chosen historically for its low cost, broad temperature stability, and compatibility with lyophilization (freeze-drying). Research continues into gelatin-free formulations, and Japanese manufacturers demonstrated a drop in immediate reaction rates when gelatin content was reduced in national products.
A 2002 CDC study by Pool and colleagues, published in Pediatrics, found that 27% of patients who experienced anaphylaxis after MMR in the United States had measurable anti-gelatin IgE antibodies on serum testing. Earlier foundational work by Sakaguchi in Japan identified gelatin IgE as the dominant cause in a population with higher baseline exposure. When manufacturers removed or reduced gelatin in Japanese MMR formulations, immediate-type reaction rates fell substantially — a natural experiment that strongly supports causation. Egg allergy, by contrast, was not associated with any of the confirmed anaphylaxis cases in these series.
It depends on the severity of the food reaction. Children with mild reactions to gelatin desserts may proceed with routine MMR after allergist review. Children with documented anaphylaxis to gelatin-containing foods should undergo specialist evaluation before vaccination, which typically includes gelatin-specific IgE blood testing and, if indicated, skin testing with the vaccine itself. If testing confirms significant gelatin IgE, the allergist can perform graded dosing (desensitization) in the office with full rescue preparedness. Most such children ultimately receive full MMR protection — the allergy is a reason for extra precaution, not a permanent exclusion.
True IgE-mediated anaphylaxis almost always begins within 15 minutes of the injection and essentially always within one hour. This is why vaccination guidelines recommend a 15 to 30-minute post-dose observation period for any patient with an atopic history. Reactions appearing hours to days later are generally NOT allergic in mechanism: delayed low-grade fever and faint morbilliform rash 5 to 12 days after MMR are expected responses to live-attenuated viral replication, and transient joint discomfort reflects the rubella component. These delayed events do not contraindicate future doses and should not be labeled as vaccine allergy.
Only in a narrow sense. MMR contains approximately 25 micrograms of neomycin as a trace antibiotic residual. Contact dermatitis from topical neomycin — the most common form of neomycin allergy — is a Type IV delayed hypersensitivity and is NOT a contraindication to vaccination; ACIP explicitly permits MMR in this scenario. Only documented IgE-mediated anaphylaxis to neomycin is a true contraindication, and such cases are extremely rare. If neomycin anaphylaxis is suspected, allergist evaluation with skin or specific IgE testing clarifies the risk before the next dose. Parents should not defer vaccination based on a diaper-rash-ointment reaction.
MMR contains measles, mumps, and rubella antigens; MMRV (ProQuad, Merck) adds varicella for a single-injection four-component vaccine. MMRV is convenient but carries a small increase in febrile seizure rate after the first dose in children 12 to 47 months compared with giving MMR and Varivax as two separate injections in the same visit. ACIP therefore recommends separate MMR + Varivax for the first dose in this age group, with MMRV acceptable for the second dose at 4 to 6 years. The gelatin and excipient profile of MMRV is similar to the combined profiles of its components — gelatin remains the primary allergen concern.
Yes. The United States declared measles elimination in 2000, but has since experienced repeated imported outbreaks culminating in near-loss of elimination status in 2019 when sustained transmission in unvaccinated communities pushed the case count past 1,200. Subsequent outbreaks have been driven by international travel combined with pockets of under-vaccination. Measles is one of the most contagious infectious diseases known — a single infected person can transmit to 12 to 18 unvaccinated contacts. The 2-dose MMR schedule is approximately 97% effective, meaning high coverage is essential for population-level protection. Unnecessary vaccine avoidance is a population health risk.
Medical References
- [1]Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. Pediatrics 2002;110(6):e71.
- [2]Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J Allergy Clin Immunol 1996;98(6 Pt 1):1058-1061.
- [3]McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol 2016;137(3):868-878.
- [4]Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012;130(1):25-43.
- [5]CDC Advisory Committee on Immunization Practices (ACIP). General Best Practice Guidelines for Immunization. Updated 2023.
- [6]Lakshman R, Finn A. MMR vaccine and allergy. Arch Dis Child 2000;82(2):93-97.
- [7]Wood RA, Berger M, Dreskin SC, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008;122(3):e771-777.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Measles Vaccine allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.